The apoptotic pathway assessments with Western blot assays confirmed that CeO2-NCs targeted to HT29 cancer cell lines altered the expression levels of the anti-apoptotic proteins Bcl2 and BclxL, and increased the expression of the Bax, PARP, and cytochrome c proteins. The gene discussed is BCL2; the disease is cancer.